Neuroprotective therapeutics preventing ERK/MAPK activation through the NMDA receptor
US7425614B2 · kind B2 · utility
0Cited by
4References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 14, 2005 |
| Grant date | Sep 16, 2008 |
| Priority date | — |
| Expiry date | Jul 14, 2025 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2510/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods for identifying neuroprotective compounds, as well as compositions and methods for treating subjects suffering from neurological diseases or disorders are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.